2025-08-07T11:35:55-05:00 2024-12-31 510229493 BARBACANE THORNTON & COMPANY LLP 593 CARR ROAD SUITE 100 WILMINGTON DE 19809 990 2024-01-01 383569922 NEPHCURE KIDNEY INTERNATIONAL NEPH 8666374287 5 CENTER AVENUE SUITE D COLLEGEVILLE PA 19426 JOSHUA TARNOFF CHIEF EXECUTIVE OFFICER 8666374287 2025-08-07 0 JEFFREY A KOWALCZYK CPA P01563311 3024788940 2025-07-30 2024 2025-03-06 01:10:19Z MICHAEL LEVINE 5 CENTER AVENUE SUITE D COLLEGEVILLE PA 19426 6187291 0 X WWW.NEPHCURE.ORG X 2000 MI NEPHCURE KIDNEY INTERNATIONAL IS THE ONLY ORGANIZATION COMMITTED EXCLUSIVELY TO SUPPORTING RESEARCH SEEKING THE CAUSE OF THE POTENTIALLY DEBILITATING KIDNEY DISEASE OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) AND NEPHROTIC SYNDROME. THE ORGANIZATION IS COMMITTED TO IMPROVING TREATMENT AND FINDING A CURE FOR THIS DISEASE. 27 27 23 380 0 0 4200803 5393306 0 0 0 0 94287 208556 4295090 5601862 200000 66250 0 0 2172246 2620675 0 0 575999 2468676 3186040 4840922 5872965 -545832 -271103 3864219 3897873 698442 880264 3165777 3017609 X NEPHCURE KIDNEY INTERNATIONAL IS THE ONLY ORGANIZATION COMMITTED EXCLUSIVELY TO SUPPORTING RESEARCH SEEKING THE CAUSE OF THE POTENTIALLY DEBILITATING KIDNEY DISEASE OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) AND NEPHROTIC SYNDROME. THE ORGANIZATION IS COMMITTED TO IMPROVING TREATMENT AND FINDING A CURE FOR THIS DISEASE. 0 0 2090904 66250 RESEARCH - NEPHCURE KIDNEY INTERNATIONAL IS COMMITTED TO MULTI-YEAR GRANTS FOR BASIC, TRANSLATIONAL, AND CLINICAL SCIENTIFIC RESEARCH. THE PURPOSE OF THIS RESEARCH IS TO DETERMINE CAUSES OF KIDNEY DISEASE, FSGS & NEPHROTIC SYNDROME THAT COULD LEAD TO EFFECTIVE TREATMENTSCLINICAL TRIAL SUPPORT - NEPHCURE KIDNEY INTERNATIONAL SUPPORTSAND FACILITATES CLINICAL RESEARCH BY ACTIVELY SUPPORTING PATIENT RECRUITMENT TO ADDRESS THE GROWING DEMAND OF CLINICAL TRIALS. 2754826 HEALTH AND EDUCATION - NEPHCURE KIDNEY INTERNATIONAL FUNDS AND MANAGES PROGRAMS TO EDUCATE PATIENTS/FAMILIES ABOUT NEPHROTIC SYNDROME & FSGS. NEPHCURE KIDNEY INTERNATIONAL ALSO PROVIDES EDUCATION MATERIALS (BI-LINGUAL) FOR PHYSICIANS AND DIRECTLY TO PATIENT FAMILIES. 4845730 1 1 0 0 0 1 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 34 0 1 23 0 0 1 CA 0 0 0 0 0 0 0 0 0 0 X 27 27 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 AL AK AZ AR CA CO CT FL GA KS KY IL LA ME MD MA MI MN MS MO NH NJ NM NY NC OK OH OR PA RI SC TN UT VA WV WA WI X THE ORGANIZATION 8666374287 5 CENTER AVENUE SUITE D COLLEGEVILLE PA 19426 IRVING SMOKLER BOARD CHAIRMAN 5.00 X X 0 0 0 CHRIS WHITNEY VICE PRESIDENT 1.00 X X 0 0 0 ANDREW SILVERMAN TREASURER 3.00 X X 0 0 0 MICHAEL LEVINE PRESIDENT 10.00 X X 0 0 0 CAROL SMOKLER SECRETARY 1.00 X X 0 0 0 ELAINE KAMIL MEMBER 1.00 X 0 0 0 DAVID KERSHAW MEMBER 1.00 X 0 0 0 WILLIAM SMOYER MEMBER 1.00 X 0 0 0 KIRK CAMPBELL MEMBER 1.00 X 0 0 0 CHARLES DAVIS III MEMBER 1.00 X 0 0 0 CHRISTOPHER WINDISCH MEMBER 1.00 X 0 0 0 JENNIFER GEISSER MEMBER 1.00 X 0 0 0 JIM DUQUETTE MEMBER 1.00 X 0 0 0 JOSHUA ROY MEMBER 1.00 X 0 0 0 KEVIN MOTT MEMBER 1.00 X 0 0 0 LEROY MILES MEMBER 1.00 X 0 0 0 LAUREL DAMASHEK MEMBER 1.00 X 0 0 0 MANU VARMA MEMBER 1.00 X 0 0 0 MARTIN ZIMMERMAN MEMBER 1.00 X 0 0 0 REBECCA OAG MEMBER 1.00 X 0 0 0 SARRETTA MCDONOUGH MEMBER 1.00 X 0 0 0 STEPHEN HOLLOMON MEMBER 1.00 X 0 0 0 TROY JONES MEMBER 1.00 X 0 0 0 SCOTT GOLDSTEIN MEMBER 1.00 X 0 0 0 EVE DRYER MEMBER 1.00 X 0 0 0 TYLER WELLMAN MEMBER 1.00 X 0 0 0 BARBARA GILLESPIE MEMBER 1.00 X 0 0 0 JOSH TARNOFF CHIEF EXECUTIVE OFFICER 40.00 X 286275 0 0 REBECCA COOK DIRECTOR DEVELOPMENT 40.00 X 119715 0 0 LAUREN EVA VP PROFESSIONAL ENGAGEMENT 1.00 X 164238 0 0 JESSIC MILTEN EXECUTIVE DIRECTOR, NATION 40.00 X 126655 0 0 BRITTA DORNAN EXECUTIVE DIRECTOR STRATEGIC RELATIONS 40.00 X 130125 0 0 827008 0 0 5 0 1 0 0 1664108 3729198 46974 5393306 95510 0 95510 95510 95510 585429 1664108 585429 0 MISCELLANEOUS REVENUE 459900 113046 113046 113046 5601862 0 0 208556 66250 66250 286275 240471 2863 42941 2334400 1960896 23344 350160 78611 43236 29872 5503 510683 280875 194059 35749 540937 332823 163248 44866 272457 231588 13623 27246 198926 163119 5968 29839 8125 8125 CLINICAL MODELING PROJE 719922 719922 PATIENT EDUCATION 501393 501393 HEALTH EQUITY 178228 178228 RESEARCH PAYMENTS 97368 97368 79390 21436 18259 39695 5872965 4845730 451236 575999 3372669 3597061 67431 97489 90552 69896 60676 60676 0 0 333567 133427 3864219 3897873 480274 789144 218168 91120 698442 880264 X 3164147 3016619 1630 990 3165777 3017609 3864219 3897873 X -271103 123574 -639 X X 0 1 X 1 0 X 3022196 3910926 4495178 4200803 5393306 21022409 3022196 3910926 4495178 4200803 5393306 21022409 21022409 21022409 1.00000 1.00000 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 1 1 0 1 35000 1 0 60676 60676 0 0 OPERATING LEASE LIABILITY 91120 91120 X 5725436 123574 123574 5601862 0 5601862 5872964 0 5872964 0 5872964 PART X, LINE 2: NEPHCURE KIDNEY INTERNATIONAL IS EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. HOWEVER, INCOME FROM CERTAIN ACTIVITIES NOT DIRECTLY RELATED TO THE ORGANIZATION'S TAX-EXEMPT PURPOSE MAY BE SUBJECT TO TAXATION AS UNRELATED BUSINESS INCOME. GENERALLY ACCEPTED ACCOUNTING PRINCIPLES PRESCRIBE RULES FOR THE RECOGNITION, MEASUREMENT, CLASSIFICATION, AND DISCLOSURE IN THE FINANCIAL STATEMENTS OF UNCERTAIN TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN THE ORGANIZATION'S TAX RETURNS. MANAGEMENT HAS DETERMINED THAT THE ORGANIZATION DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS OR ASSOCIATED UNRECOGNIZED BENEFITS THAT MATERIALLY IMPACT THE FINANCIAL STATEMENTS OR RELATED DISCLOSURES. SINCE TAX MATTERS ARE SUBJECT TO SOME DEGREE OF UNCERTAINTY, THERE CAN BE NO ASSURANCE THAT THE ORGANIZATION'S TAX RETURNS WILL NOT BE CHALLENGED BY THE TAXING AUTHORITIES AND THAT THE ORGANIZATION WILL NOT BE SUBJECT TO ADDITIONAL TAX, PENALTIES, AND INTEREST AS A RESULT OF SUCH CHALLENGE. CDTAC NY 980848 700106 280742 280742 TAMPA PIG JIG 467000 465094 1906 1906 12 801689 498908 302781 302781 2249537 1664108 585429 585429 585429 0 1 DUKE UNIVERSITY 2080 DUKE UNIVERSITY ROAD DURHAM NC 27708 562070036 50000 0 RESEARCH GRANT UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 200 E CAMERON AVENUE CHAPEL HILL NC 27514 566001393 16250 0 RESEARCH GRANT X X 0 0 0 0 0 0 0 0 0 JOSH TARNOFF CHIEF EXECUTIVE OFFICER 286275 0 0 0 0 0 0 0 0 0 286275 0 0 0 LAUREN EVA VP PROFESSIONAL ENGAGEMENT 164238 0 0 0 0 0 0 0 0 0 164238 0 0 0 X VARIOUS DONATED GOODS 72 46974 0 0 0 FORM 990, PART VI, SECTION A, LINE 2 TWO BOARD MEMBERS ARE RELATED BY MARRIAGE FORM 990, PART VI, SECTION B, LINE 11B A FINAL COPY OF FORM 990 IS PROVIDED TO EACH VOTING MEMBER OF THE GOVERNING BOARD. FORM 990, PART VI, SECTION B, LINE 12C THE BOARD REVIEWS COMPLETED CONFLICT OF INTEREST QUESTIONNAIRES AND DISCLOSES INFORMATION DURING THE ANNUAL BOARD MEETING FOR BOARD APPROVAL. FORM 990, PART VI, SECTION C, LINE 19 990 AVAILABLE UPON REQUEST. FORM 990, PART XI, LINE 9: OPENING BALANCE ADJUSTMENT FOR IMPLEMENTATION OF FAS TOPIC 842 -639. FORM 990 PART XII LINE 2C THE PROCESS HAS NOT CHANGED FROM PRIOR YEAR